Načítá se...
A Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B
Chronic infection by the hepatitis B virus (HBV) has remained a major public health problem. To achieve an HBV cure, we will likely need to combine antivirals with different viral targets as well as immunotherapy. Here, we report data from a pilot proof‐of‐concept clinical trial of nitazoxanide in t...
Uloženo v:
| Vydáno v: | Hepatol Commun |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546020/ https://ncbi.nlm.nih.gov/pubmed/31168509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1339 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|